Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of …

Y Hanai, Y Takahashi, T Niwa, T Mayumi… - Journal of …, 2022 - academic.oup.com
Background Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …

Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment

JP Lynch III, GG Zhanel - Expert Review of Anti-infective Therapy, 2023 - Taylor & Francis
Introduction MRSA is associated with causing a variety of infections including skin and skin
structure infections, catheter and device-related (eg central venous catheter, prosthetic heart …

[HTML][HTML] Validation of vancomycin area under the concentration—Time curve estimation by the Bayesian approach using one-point samples for predicting clinical …

T Ueda, Y Takesue, K Nakajima, K Ichiki, K Ishikawa… - Antibiotics, 2022 - mdpi.com
Area under the concentration–time curve (AUC)-guided vancomycin treatment is associated
with decreased nephrotoxicity. It is preferable to obtain two samples to estimate the AUC …

Optimal trough concentration of teicoplanin for the treatment of methicillin‐resistant Staphylococcus aureus infection: A systematic review and meta‐analysis

Y Hanai, Y Takahashi, T Niwa, T Mayumi… - Journal of Clinical …, 2021 - Wiley Online Library
What is known and objective It has been recommended that the trough concentration (Cmin)
of teicoplanin should be maintained at≥ 20 μg/ml for difficult‐to‐treat complicated infections …

[HTML][HTML] A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China

L Xie, L Ding, L Tang, Z Yang, D Wu, W Wang… - BMC Health Services …, 2023 - Springer
Background and objective Currently, the detection rates of methicillin-resistant S. aureus
(MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCoNS) in the blood …

[HTML][HTML] Necessity for higher teicoplanin doses in older adults: a multicenter prospective observational study in China

T Liu, J Wu, P Na, X Wu, Y Yuan, C Wang, X Ma, L Qi… - BMC geriatrics, 2024 - Springer
Background Many older adult patients receive low-dose teicoplanin with varied regimens,
leading to a lack of clarity on its optimal regimens and toxicity profiles in China. This study …

Are antibiotics appropriately dosed in critically ill patients with augmented renal clearance? A narrative review

M Sistanizad, R Hassanpour… - International Journal of …, 2022 - Wiley Online Library
Aims. Augmented renal clearance (ARC), which is commonly defined as increased renal
clearance above 130 ml/min/1.73 m2, is a common phenomenon among critically ill …

Therapeutics for vancomycin-resistant enterococcal bloodstream infections

KA Cairns, AA Udy, TN Peel, IJ Abbott… - Clinical Microbiology …, 2023 - Am Soc Microbiol
Vancomycin-resistant enterococci (VRE) are common causes of bloodstream infections
(BSIs) with high morbidity and mortality rates. They are pathogens of global concern with a …

Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant …

XS Zhang, YL Chen, YZ Wang, C Chen… - British Journal of …, 2024 - Wiley Online Library
Aims This study aims to establish a population pharmacokinetic (PK) model of teicoplanin in
Chinese adult patients to evaluate the dosing regimen in the label sheet and optimize it …

[HTML][HTML] Dose optimization of teicoplanin for critically ill patients with renal dysfunction and continuous renal replacement therapy: experience from a prospective …

L Shi, Z Zhuang, L Duan, C Zhu, H Xue… - Frontiers in …, 2022 - frontiersin.org
Background: Due to the lack of updated information on teicoplanin (TEI) for continuous renal
replacement therapy (CRRT), no exact dosage regimen has been recommended. The aim of …